ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2020

Quality-of-Life Comparison of Dapagliflozin Versus Dipeptidyl Peptidase 4 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (J-BOND Study).

Hitoshi Ishii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.